The Hemophilia and Thrombosis Treatment Center at UC San Diego Health has joined a nationwide clinical trial testing a potential gene therapy that may one day provide a better and long-lasting treatment for people with hemophilia B.
Long-term declines in the overwintering eastern population of North American monarch butterflies are significantly increasing their likelihood of becoming extinct over the next two decades, according to Scripps Institution of Oceanography at UC San Diego and U.S. Geological Survey research published today.
With Calit2 Director Larry Smarr slated to accept an award at CENIC's annual meeting on the UC Davis campus next week, the principal investigator of the Pacific Research Platform (PRP) answers questions about the project which got underway last October 1.
A recent study by researchers at University of California, San Diego School of Medicine reports that educating community health workers and other “citizen scientists” can improve knowledge of basic research concepts and ultimately boost the integrity of scientific research.
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine approved yesterday a $6.3 million grant to a research team from the University of California, San Diego School of Medicine and University of California, Davis to pursue a novel human embryonic stem cell-based therapy to rescue and restore neurons devastated by amyotrophic lateral sclerosis or ALS.
Scientists have long sought an efficient method for targeting RNA— intermediary genetic material that carries the genetic code from the cell’s nucleus to protein-making machinery — in living cells. Researchers at University of California, San Diego School of Medicine have now achieved this by applying the popular DNA-editing technique CRISPR-Cas9 to RNA. The study is published March 17 in Cell.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
